David P Richman, MD


  • 3225 Citations
  • 31 h-Index
1969 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 5 Similar Profiles
Cholinergic Receptors Medicine & Life Sciences
Myasthenia Gravis Medicine & Life Sciences
Autoimmune Experimental Myasthenia Gravis Medicine & Life Sciences
Monoclonal Antibodies Medicine & Life Sciences
Torpedo Medicine & Life Sciences
Nicotinic Receptors Medicine & Life Sciences
Antibodies Medicine & Life Sciences
Bungarotoxins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1979 2013

Animal Models
Neuromuscular Junction
Muscle Weakness
Myasthenia Gravis
Lambert-Eaton Myasthenic Syndrome
Fees and Charges
Clinical Pharmacology


Fairclough, R. H., Richman, D. P., Nelson, D., Martinez-Carrion, M. & Kezdy, F.

National Institutes of Health


Project: Research project

Cholinergic Receptors
Blocking Antibodies
Monoclonal Antibodies
Myasthenia Gravis
Monoclonal Antibodies
Cholinergic Receptors
Autoimmune Diseases

Research Output 1969 2018

4 Citations (Scopus)

3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia

Sanders, D. B., Juel, V. C., Harati, Y., Smith, A. G., Peltier, A. C., Marburger, T., Lou, J. S., Pascuzzi, R. M., Richman, D. P., Xie, T., Demmel, V., Jacobus, L. R., Aleš, K. L. & Jacobus, D. P., Jan 1 2018, (Accepted/In press) In : Muscle and Nerve.

Research output: Contribution to journalArticle

Pharmaceutical Preparations
4 Citations (Scopus)

Developing treatment guidelines for myasthenia gravis

The MGFA Task Force On Mg Treatment Guidance, Jan 1 2018, In : Annals of the New York Academy of Sciences. 1412, 1, p. 95-101 7 p.

Research output: Contribution to journalReview article

Intravenous Immunoglobulins
Myasthenia Gravis
Immunosuppressive Agents
Protein-Tyrosine Kinases


Sanders, D. B., Harati, Y., Juel, V. C., Lou, J. S., Marburger, T., Pascuzzi, R. M., Peltier, A. C., Richman, D. P. & Smith, A. G., May 1 2018, In : Muscle and Nerve. 57, 5, p. E130-E131

Research output: Contribution to journalLetter

3 Citations (Scopus)

A nicotinic receptor optical biosensor

Rogers, K. R., Eldefrawi, M. E. & Richman, D. P., Jan 1 2017, Biosensor Technology: Fundamentals and Applications. CRC Press, p. 383-390 8 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Nicotinic Receptors
Biosensing Techniques
Neurotransmitter Receptor
Street Drugs
3 Citations (Scopus)

Population pharmacokinetics/pharmacodynamics of 3,4-diaminopyridine free base in patients with Lambert-Eaton myasthenia

Thakkar, N., Aleš, K., Jacobus, D., Jacobus, L., Peloquin, C., Cohen-Wolkowiez, M., Gonzalez, D., Juel, V. C., Guptill, J. T., Massey, J. M., Hobson-Webb, L. D., Beck, K., Harati, Y., Arvantaj, A., Phan, C., Mousavi, S., Mac-Adam, C., Smith, A. G., Rob Singleton, J., Latner, C. & 24 othersLessard, M., Peltier, A., Donofrio, P., Lee, C., Artibee, K., Lou, J. S., Marburger, T., Dimitrova, A., Burroughs, B., Jafari, G., Khoury, J., Satayaprasert, M., Dimitrova, D., Pascuzzi, R. M., Bodkin, C., Kincaid, J., Snook, R., Micheels, A., Guingrich, S., Richman, D. P., Agius, M. A., Butters, J., Lindsay, M. & Khalatyan, V., Sep 1 2017, In : CPT: Pharmacometrics and Systems Pharmacology. 6, 9, p. 525-534 10 p.

Research output: Contribution to journalArticle

Orphan Drug Production
Investigational Drugs